S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
OTCMKTS:USAQ

QHSLab (USAQ) Stock Price, News & Analysis

$0.10
+0.04 (+66.67%)
(As of 03/27/2024 ET)
Today's Range
$0.05
$0.11
50-Day Range
$0.04
$0.18
52-Week Range
$0.02
$0.25
Volume
3,650 shs
Average Volume
30,315 shs
Market Capitalization
$974,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
USAQ stock logo

About QHSLab Stock (OTCMKTS:USAQ)

QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It also develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. In addition, the company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida.

USAQ Stock Price History

USAQ Stock News Headlines

QHSLab, Inc. (OTCMKTS:USAQ) Short Interest Update
Warning: this could blow your mind
Buckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…
US Elections
QHSLab reports Q3 results
Major Elon Musk Crypto Leak Revealed
Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.
Us & Them
US B-Schools Ranking
US Cotton #2 Futures - Dec 23 (CTZ3)
US Dollar Report News Headlines | Reuters
8-K: QHSLab, Inc.
See More Headlines
Receive USAQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for QHSLab and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/16/2021
Today
3/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
OTCMKTS:USAQ
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Net Income
$-1,000,000.00
Pretax Margin
-43.94%

Debt

Sales & Book Value

Annual Sales
$1.24 million
Book Value
$0.01 per share

Miscellaneous

Free Float
2,513,000
Market Cap
$974,000.00
Optionable
Not Optionable
Beta
-0.20
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Troy James Grogan (Age 47)
    CEO, CFO, President & Chairman
  • Olivia Giamanco
    Marketing Director
  • Ms. Cyndi Cole CPA
    M.B.A., Financial Controller

USAQ Stock Analysis - Frequently Asked Questions

Should I buy or sell QHSLab stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for QHSLab in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" USAQ shares.
View USAQ analyst ratings
or view top-rated stocks.

How have USAQ shares performed in 2024?

QHSLab's stock was trading at $0.09 on January 1st, 2024. Since then, USAQ shares have increased by 11.1% and is now trading at $0.10.
View the best growth stocks for 2024 here
.

Are investors shorting QHSLab?

QHSLab saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 23,200 shares, an increase of 11,500.0% from the February 29th total of 200 shares. Based on an average daily trading volume, of 71,400 shares, the days-to-cover ratio is currently 0.3 days.
View QHSLab's Short Interest
.

How were QHSLab's earnings last quarter?

QHSLab, Inc. (OTCMKTS:USAQ) issued its quarterly earnings data on Tuesday, November, 16th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by $0.01. The firm had revenue of $0.32 million for the quarter. QHSLab had a negative net margin of 43.94% and a negative trailing twelve-month return on equity of 9,878.04%.

How do I buy shares of QHSLab?

Shares of USAQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:USAQ) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners